Briacell Therapeutics Corp (CVE:BCT)

Briacell Therapeutics Corp (CVE:BCT)


Share Price
$ 0.08
Change
-0.01 (-11.11 %)
Market Cap
$15.29 m
Proactive Investors - Run By Investors For Investors

Briacell Therapeutics Corp

BriaCell is a clinical stage immuno-oncology focused biotechnology company developing the first off-the-shelf personalized immunotherapy targeting advanced breast cancer.

EPIC: BCT
Market: TSX-V:BCT
OTCQB:BCTXF
FRA:8BT
52-week High/Low: C$0.18 / C$0.07
Sector: Pharma & Biotech
Market Cap: $15.29 m
Website: briacell.com
col 3
col 4
col 5
col 6

Briacell Therapeutics Corp Timeline

Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use